<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">Polymyositis</z:e> (PM) is one of the <z:hpo ids='HP_0009071'>inflammatory myopathies</z:hpo>, disorders characterized pathologically by the presence of inflammatory infiltrates in striated muscle </plain></SENT>
<SENT sid="1" pm="."><plain>The principal clinical manifestation of PM is <z:hpo ids='HP_0003701'>proximal muscle weakness</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The cause of PM is unknown, but current evidence suggests that it is an <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>PM can affect people of any age, but most commonly presents between the ages of 50 to 70 </plain></SENT>
<SENT sid="4" pm="."><plain>PM is rarely seen in people younger than 18 years of age, and is twice as common among females than males </plain></SENT>
<SENT sid="5" pm="."><plain>PM is more common in blacks than in whites </plain></SENT>
<SENT sid="6" pm="."><plain>The overall prevalence of PM is 1 per 100,000 </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0001324'>Muscle weakness</z:hpo> may develop suddenly or more insidiously over a period of weeks to months </plain></SENT>
<SENT sid="8" pm="."><plain>The classic symptom of PM is proximal <z:mp ids='MP_0000746'>weakness</z:mp>, which may manifest as difficulty holding the arms over the head, climbing stairs, or rising from a chair </plain></SENT>
<SENT sid="9" pm="."><plain><z:mp ids='MP_0000746'>Weakness</z:mp> of the striated muscle of the upper esophagus may result in <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, <z:hpo ids='HP_0001618'>dysphonia</z:hpo>, and <z:hpo ids='HP_0002835'>aspiration</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The chest wall muscles may be affected, leading to ventilatory compromises </plain></SENT>
<SENT sid="11" pm="."><plain>Involvement of cardiac muscle may lead to <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain><z:e sem="disease" ids="C0011633" disease_type="Disease or Syndrome" abbrv="">Dermatomyositis</z:e> (DM) is closely related to PM, and both are distinguished primarily by the occurrence of characteristic <z:mp ids='MP_0002096'>skin abnormalities</z:mp> in the former </plain></SENT>
<SENT sid="13" pm="."><plain>PM and DM may be associated with a variety of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>PM may also occur as part of the spectrum of other <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic diseases</z:e> like <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and <z:e sem="disease" ids="C0026272" disease_type="Disease or Syndrome" abbrv="MCTD">mixed connective tissue disease</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>Moreover, <z:hpo ids='HP_0009071'>inflammatory myopathy</z:hpo> may be caused by some drugs (<z:chebi fb="0" ids="8428">procainamide</z:chebi>, <z:chebi fb="0" ids="7959">D-penicillamine</z:chebi>), and viruses, most notably the retroviruses </plain></SENT>
<SENT sid="16" pm="."><plain><z:chebi fb="0" ids="50858">Corticosteroids</z:chebi> and <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> are the mainstays of therapy for PM </plain></SENT>
<SENT sid="17" pm="."><plain>The principal goals of therapy are to improve strength and improve physical functioning </plain></SENT>
<SENT sid="18" pm="."><plain>Many patients require treatment for several years </plain></SENT>
<SENT sid="19" pm="."><plain>The 5-year survival rate for treated patients is in the order of 95% </plain></SENT>
<SENT sid="20" pm="."><plain>Up to one-third of PM patients may be left with some degree of residual <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> </plain></SENT>
</text></document>